Finance

Lists
Q2 2027 earnings • released • EPS beat +258.45% • Revenue beat +12.22%
See results
APLLTD:NSE
Alembic Pharmaceuticals Ltd
₹1,033.80
+15.70%
(+140.30) 1D
ኖቬም 8, 3:30:01 ከሰዓት ጂ ኤም ቲ+530  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
₹894.80
High
₹985.00
Low
₹890.00
Mkt. cap
198.14 ቢ
Avg. vol.
354.14 ሺ
Volume
0.00
Dividend
1.16%
Quarterly dividend
₹3.00
Ex-dividend date
29 ጁላይ 2026
P/E ratio
24.09
52-wk high
₹985.00
52-wk low
₹635.80
EPS
₹42.92
Shares outstanding
188.50 ሚ
No. of employees
17 ሺ
Open
₹894.80
High
₹985.00
Low
₹890.00
Mkt. cap
198.14 ቢ
Avg. vol.
354.14 ሺ
Volume
0.00
Dividend
1.16%
Quarterly dividend
₹3.00
Ex-dividend date
29 ጁላይ 2026
P/E ratio
24.09
52-wk high
₹985.00
52-wk low
₹635.80
EPS
₹42.92
Shares outstanding
188.50 ሚ
No. of employees
17 ሺ
News stories
From web sources and news partners
About Alembic Pharmaceuticals Ltd
CEO-
Employees17.2 ሺ
Founded1907
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Website-
Last report
4 ኖቬም 2026
Fiscal period
Q2 2027
₹39.31 / ₹10.97
+258.45%beat
Revenue / Est. (INR)
26.19 ቢ / 23.34 ቢ
+12.22%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
18.76 ቢ
18.48 ቢ
21.50 ቢ
26.19 ቢ
Cost of goods sold
5.29 ቢ
6.27 ቢ
6.20 ቢ
6.86 ቢ
Cost of revenue
5.29 ቢ
6.27 ቢ
6.20 ቢ
6.86 ቢ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.33 ቢ
4.39 ቢ
4.74 ቢ
5.04 ቢ
Operating expense
11.34 ቢ
10.85 ቢ
12.96 ቢ
14.55 ቢ
Total operating expenses
16.63 ቢ
17.11 ቢ
19.16 ቢ
21.41 ቢ
Operating income
2.13 ቢ
1.36 ቢ
2.34 ቢ
4.78 ቢ
Other non operating income
154.90 ሚ
-285.60 ሚ
149.30 ሚ
100.00 ሺ
EBT including unusual items
1.61 ቢ
1.19 ቢ
2.22 ቢ
4.38 ቢ
EBT excluding unusual items
2.04 ቢ
1.37 ቢ
2.22 ቢ
4.38 ቢ
Income tax expense
295.40 ሚ
-829.00 ሚ
495.00 ሚ
1.04 ቢ
Effective tax rate
18.29%
-69.88%
22.31%
23.76%
Other operating expenses
6.21 ቢ
5.56 ቢ
7.24 ቢ
8.51 ቢ
Net income
1.33 ቢ
2.03 ቢ
1.73 ቢ
3.35 ቢ
Net profit margin
7.09%
10.97%
8.05%
12.80%
Earnings per share
8.51
11.57
8.80
39.31
Interest and investment income
-
8.60 ሚ
-
-
Interest expense
-233.10 ሚ
-225.60 ሚ
-276.10 ሚ
-382.60 ሚ
Net interest expenses
-233.10 ሚ
-217.00 ሚ
-276.10 ሚ
-382.60 ሚ
Depreciation and amortization charges
801.20 ሚ
885.90 ሚ
977.10 ሚ
1.01 ቢ
EBITDA
2.78 ቢ
2.12 ቢ
3.09 ቢ
5.77 ቢ
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች